期刊文献+

210例老年肺癌的临床分析 被引量:2

A clinical analysis of 210 aged patients with lung cancer
暂未订购
导出
摘要 目的:了解老年肺癌的临床特征、诊治特点和生存状态。方法:对210例60岁以上肺癌患者临床资料进行回顾分析。结果:老年肺癌以男性居多,吸烟比例高;咳嗽、咳痰、咯血、低热、气短等为首发症状,15.3%合并慢性肺疾病;误诊率23.3%,以呼吸道感染、肺结核为主;纤维支气管镜检查为主要确诊手段,鳞癌居多,腺癌、小细胞癌次之;Ⅲ a-Ⅳ期肺癌占贷.2%;化疗、生物免疫制剂及中药治疗为主,手术仅占11.9%。结论:老年肺癌临床症状不典型,容易误诊,确诊时大多为晚期,所以对于有大量吸烟史、合并慢性肺疾病者等肺癌高危人群应定期查体、宣教,警惕久治不愈的呼吸道症状的变化。早期诊断,采取有效积极的治疗措施,可提高老年肺癌患者的生存期,改善生存状态。 Objective:To investigate the clinical features , and state in the aged patients with lung cancer. Methods:A retrospective analysis was used, the data came from hospitalized cases. Results:Old males and smoking persons were more among all 210 patients with lung cancer . The fist symptom were cough, spit sputum, hemoptysis , low fever, dyspnea ,etc. There were 15.3% patients with chronic lung diseases. The misdiagnosis rate was 23.3%, sach as respiratory tract infection, tuberculosis, etc. The fiber bronchus mirror check was main method of diagnosis. The lung scale cancer was mostly in all cases, next gland cancer and small cell lung cancer. The Ⅲ a-Ⅳ stage lung cancer in 65.2% , operation therapy in 11.9%. Conclusion:The clinical symptom of aged patients with lung cancer isnt typical, diagnosis are not easy. So for the dangerous people who had long smoking history and with chronic lung diseases, should periodically health check -up and health teaching to prevent lung cancer.
出处 《现代肿瘤医学》 CAS 2006年第5期568-569,共2页 Journal of Modern Oncology
关键词 老年人 肺癌 诊断 治疗 aged lung cancer diagnosis treatment
  • 相关文献

参考文献5

二级参考文献22

  • 1陆启裕,华晓芳.60岁以上老干部26例肺癌临床分析[J].广西医科大学学报,1994,11(2):229-231. 被引量:2
  • 2毋永娟,桑涛,杨燕霞,钱森.28例老年人肺癌临床分析[J].内蒙古医学杂志,1995,15(3):144-145. 被引量:1
  • 3廖美琳.老年肺癌流行病学及临床特点[J].实用老年医学,1997,11(2):60-61. 被引量:8
  • 4袁小玲 吴卫辉 等.经纤维支气管镜插管腔内放射治疗气道肿瘤[J].中华结核和呼吸杂志,1994,17(6):378-378.
  • 5[1]Stephens RJ, Fairlamb N, Gower N, et al. The Big Lung Trial (BLT): determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting. Proc Am Soc Clin Oncol,2002,21:291a.
  • 6[2]Effects of vinorelbine on quality of life and survival in elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study (ELVIS) Group. J Natl Cancer Inst,1999,91(1):66-72.
  • 7[3]Lilenbaum RC, Herndon JE, List M, et al. Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: a CALGB randomized trial of efficacy, quality of life and cost-effectiveness. Proc Am Soc Clin Oncol,2002,21:1a.
  • 8[4]Scagliotti GV, De Marinis F, Rinaldi M, et al. Phase Ⅲ randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. J Clin Oncol,2002,20(21):4285-4291.
  • 9[5]Fossella FV, DeVore R, Kerr RN, et al. Randomized phase Ⅲ trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. J Clin Oncol,2000,18(12):2354-2362.
  • 10[6]America Society of Clinical Oncology: Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. J Clin Oncol,1997,15(8):2996-3018.

共引文献52

同被引文献3

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部